GlassScriptPhysician profile
Robert L Weiss
NPI 1538241484
$5,920.34
in general payments reported to CMS, 2019-2025
14 companies · $992 in 2025
The $992 reported for 2025 was more than what 79% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $138 · 2021: $2,938 · 2022: $365 · 2023: $394 · 2024: $685 · 2025: $992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,071.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $3,099.14 | 2019-2022 | |
| Neurent Medical Limited | $637.52 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Stryker Corporation | $440.19 | 2019-2025 | Xpress Loprofile, Clarifix Cryotherapy Device |
| Glaxosmithkline, LLC. | $431.46 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $242.61 | 2019-2025 | Dupixent |
| Nevro Corp. | $242.28 | 2023-2024 | Senza |
| Optinose US, INC. | $223.95 | 2024-2025 | |
| Medtronic, INC. | $184.36 | 2023 | Propel |
| Xoran Technologies LLC | $178.44 | 2021 | |
| Spirair, INC. | $135.96 | 2025 | |
| Acclarent, INC | $30.25 | 2019-2020 | |
| Kaleo, INC. | $26.19 | 2024 | Auvi-Q |
| Aerin Medical INC. | $25.93 | 2025 | |
| Genzyme Corporation | $22.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.